Enlighten Spokane
The personal use of entheogenic medicines shouldn't be criminalized.
06/07/2026
Louisiana lawmakers sent a bill to create a psychedelic-assisted therapy pilot program, funded by opioid settlement dollars, to the governor.
Louisiana Lawmakers Pass Bill To Create Psychedelic Therapy Pilot Program Funded By Opioid Settlement Dollars, Sending It To Governor - Ma*****na Moment Louisiana lawmakers have sent the governor a bill to create a psychedelic-assisted therapy pilot program, using opioid settlement dollars to fund clinical trials aimed at developing alternative treatments such as psilocybin, ibogaine and M**A. The Senate signed off the final version of the proposal....
The largest psychedelic trial yet found that one or two doses of psilocybin with psychotherapy produced antidepressant effects for up to a year.
05/31/2026
Attorneys are pressing the DEA to reschedule psilocybin, especially after Trump’s executive order made the delay harder to justify.
DEA Should 'Promptly Move Forward' With Psilocybin Rescheduling In Light Of Trump's Psychedelics Order, Attorney For Doctor Behind Petition Says - Ma*****na Moment The Drug Enforcement Administration (DEA) is being put on notice—again—over prolonged delays in processing a petition to reschedule psilocybin from a doctor who wants to use it to treat terminally ill patients, with an updated reminder that President Donald Trump has now made clear his administr...
05/17/2026
30 bipartisan U.S. House members cosigned a letter to the FDA requesting clarity on its response to the psychedelics executive order.
Bergman, Correa Lead Letter Urging FDA to Expedite Review of Breakthrough Mental Health Therapies Millions of Americans continue to struggle with complex mental health challenges, and for many, existing treatment options fall short. This gap in care is felt acutely among Veterans, who experience rates of PTSD, depression, and su***de far exceeding those of the general population, and it has cont...
05/17/2026
In a small pilot trial, adults who microdosed L*D twice a week saw a 60% drop in depression severity.
L*D microdosing linked to acute mood improvements in adults with depression A new pilot study suggests that taking small, sub-perceptual doses of L*D could temporarily boost feelings of creativity and social connection in individuals with major depression. However, researchers caution that placebo-controlled trials are still needed.
1,529 psychedelic users cited health benefits, personal growth, and life-changing shifts in perspective as their biggest takeaways.
https://journals.sagepub.com/doi/10.1177/00914509261444382?utm_source=tricycleday&utm_medium=newsletter&utm_campaign=this-week-in-psychedelics&_bhlid=7b6c1ba1b8365eec2210322d0c717feaf36db6c1
Click here to claim your Sponsored Listing.
Category
Contact the organization
Website
Address
Spokane, WA
99218